Jefferies repeats a purchase on CVS Health (CVS) with PT $ 80

CVS Health Corporation (Nyse:CVSIt is one of the top Most of the shares of low fluctuations are less than their value for purchase now. In a report released on August 19, Brian Tankoyleut from Jeffrez reiterated a purchase classification on CVS Health Corporation (NYSE: CVS), setting a goal for $ 80.00.

In a report issued on August 18, UBS also upgraded shares to a price of $ 79.00.

CVS Health Corporation (NYSE: CVS) reported the financial results of Q2 2025 on July 31, with total revenue for a quarter that rose to 98.9 billion dollars, an increase of 8.4 % compared to the previous year.

The diluted GAAP EPS was $ 0.80, while the modified EPS was $ 1.81. The company also established $ 6.5 billion in cash flows a year to the date of operations.

The average share price of $ 71.93 is targeted, as well as a rise of 11.91 % of the current levels.

CVS Health Corporation (NYSE: CVS) is a healthy solution company working in four sectors: health care advantages, health services, pharmacy, consumer, and companies/others. Aside from being a prominent pharmacy chain, the company is one of the largest health insurance companies in the United States through its Aetna operations.

While we acknowledge the biographical potential as an investment, we believe that some of the artificial intelligence shares provide greater potential in the upward direction and carry less negative risks. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read the following: 30 stocks must double in 3 years and 11 stocks of hidden artificial intelligence for purchase now.

Detection: Nothing. This article was originally published in A monkey from the inside.